CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled
Drug / intervention
Retinol Complex 0.5 +4 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03302559
NCT03302559N/ACompleted
CompareCT.gov

Assessing the Cosmetic Changes in the Facial Skin Utilizing Non-Invasive In Vivo Skin Imaging Instrumentation After Use of a Topical Retinoid Product In Subjects With Moderate to Severe Photodamage

Allergan·interventional·Posted Oct 5, 2017·Updated Jun 4, 2019

In Brief

A clinical study evaluating Retinol Complex 0.5, Facial cleanser, and 3 other interventions for Skin Care. Completed, enrolled 29 participants across 1 site.

Detailed Summary

This study will assess the cosmetic changes of a cosmetic topical retinoid product in participants with moderate to severe photodamage utilizing non-invasive in vivo skin imaging instrumentation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Care
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 5, 2017
Enrollment StartSep 18, 2017
Primary CompletionApr 30, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.7 years ago

Interventions

Retinol Complex 0.5other

Retinol Complex 0.5 topically in the evening.

Facial cleanserother

Facial cleanser in the morning and in the evening.

Moisturizing lotionother

Fragrance free moisturizing lotion in the morning and in the evening.

Sunscreenother

Sunscreen broad spectrum sun protection factor (SPF) 35 topically in the morning and as needed.

Skin Imagingdevice

Non-invasive in vivo skin imaging will be taken with the VivoSight Dx Optical Coherence Tomography (OCT) and VivaScope 1500